X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/12/05/2790860/0/en/Aspargo-Laboratories-Inc-Announces-Completion-of-Dosing-of-All-Subjects-in-Sildenafil-Oral-Suspension-Bioavailability-Study-and-Initiation-of-Dosing-in-Companion-Food-Effect-Study.html
https://www.globenewswire.com//news-release/2023/09/19/2745556/0/en/Aspargo-Laboratories-Inc-Announces-Initial-Dosing-of-All-Subjects-in-Bioavailability-Study-for-Sildenafil-Oral-Suspension.html
https://www.globenewswire.com//news-release/2023/09/05/2737281/0/en/Aspargo-Laboratories-Announces-IND-Clearance-by-U-S-FDA-Enabling-Launch-of-Bioequivalence-and-Food-Effect-Studies-for-Sildenafil-Oral-Spray.html
https://www.globenewswire.com/news-release/2023/08/01/2715760/0/en/Aspargo-Laboratories-Inc-Announces-Filing-of-Its-Investigational-New-Drug-Application-for-Sildenafil-Oral-Spray.html
https://www.globenewswire.com/news-release/2023/01/24/2594140/0/en/Aspargo-Receives-Regulatory-Approval-to-Market-Sildenafil-Spray-in-Germany-Ireland-and-The-Netherlands.html
https://www.globenewswire.com//news-release/2022/11/29/2563971/0/en/Aspargo-Extends-Latin-America-Reach-From-Mexico-to-Argentina.html
https://www.globenewswire.com/news-release/2022/10/04/2527723/0/en/Aspargo-s-Global-Footprint-Grows-With-Middle-East-Expansion-Disrupting-the-Erectile-Dysfunction-Market-With-Oral-Spray.html
https://www.globenewswire.com/news-release/2022/06/21/2466118/0/en/Aspargo-Expands-Beyond-Spain-Into-Latin-America-Disrupting-Erectile-Dysfunction-ED-Market-With-Oral-Spray.html
https://www.globenewswire.com/news-release/2022/05/04/2435610/0/en/Aspargo-Acquires-Bandol-Sildenafil-Spray-Currently-Marketed-In-Spain.html
https://www.globenewswire.com/news-release/2020/09/29/2100569/0/en/Aspargo-Laboratories-Inc-Acquires-International-Rights-to-Sildenafil-Oral-Spray-for-the-Treatment-of-Erectile-Dysfunction.html
Market Place
Share 
